Marco Bortolato

School of Pharmacy - Pharmacology & Toxicology
Assistant Professor
Primary office:
Malott Hall
Room 5040
University of Kansas
1251 Wescoe Hall Dr.
Lawrence, KS 66045

Dr. Marco Bortolato's research is primarily focused on the characterization of the biological bases of neurodevelopmental disorders through the employment of behavioral tests in animal models.

Research Interests

  • Translational Studies in Neuropsychopharmacology
  • Animal models of neurodevelopmental and impulse-control disorders (schizophrenia and psychotic disorders, Tourette syndrome, autism-spectrum disorder, pathological aggression
  • Pathological gambling
  • Bipolar disorder)
  • Behavioral pharmacology and neuroscience
  • Drug discovery and clinical trials/studies in Neuropsychiatry

2nd among all schools of pharmacy in National Institutes of Health funding
Brings more than $20 million in external funding into the state each year
7 of 19 cancer drugs formulated through the National Cancer Institute were developed at the KU School of Pharmacy
3,000 free flu shots given to needy Kansans during the past 5 years
4,000 living alumni, 63 percent of them living and working in Kansas
KU pharmacists practice in 95 of Kansas’ 105 counties
20th among public schools of pharmacy.
—U.S. News & World Report
$20.2 million NIH research grant earned by Distinguished Professor Jeff Aubé was 2nd largest in Kansas history
100 percent placement after graduation for KU Pharm.D. students
Established in 1885 as the 1st professional program at KU
KU Today